{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:51:44Z","timestamp":1771030304290,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>We provide a timely update on treatment care issues facing clinicians and patients with acute pulmonary embolism accompanied by either right ventricular strain (sub-massive pulmonary embolism) or shock (massive pulmonary embolism).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Care and research changes over the last several years have resulted in four important trends: more consensus and accuracy in the way acute pulmonary embolism severity is described and communicated among acute care clinicians and researchers, increased availability and use of risk prediction scoring systems, increased use of advanced invasive therapy in the setting of severe right ventricular dysfunction, and emergence of multidisciplinary pulmonary embolism response teams to guide standard care decision-making.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Pulmonary embolism with shock should be treated with either systemic or catheter-based thrombolytic therapy in the absence of contraindications. Patients with sub-massive pulmonary embolism accompanied by right heart dysfunction who are treated with thrombolytic therapy likely will experience more rapid improvement in RV function and are less likely to progress to hemodynamic decompensation. This comes, however, with an increased risk of major bleeding. Our recommendation is to consider catheter-based or systemic fibrinolytic therapy in sub-massive pulmonary embolism cases where patients demonstrate high-risk features such as: severe RV strain on echo or CT, and importantly worsening over time trends in pulse, SBP, and oxygenation despite anticoagulation. Understanding the impact of advanced therapy beyond standard anticoagulation on patient-centered outcomes, such as functional status and quality of life represent a research knowledge gap.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000558","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T08:49:45Z","timestamp":1539593385000},"page":"540-546","source":"Crossref","is-referenced-by-count":9,"title":["Pulmonary embolism critical care update: prognosis, treatment, and research gaps"],"prefix":"10.1097","volume":"24","author":[{"given":"Jason D.","family":"Chodakowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Mark","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"829.e5","DOI":"10.1016\/j.amjmed.2014.03.041","article-title":"Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE Study (1985-2009)","volume":"127","author":"Huang","year":"2014","journal-title":"Am J Med"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacc.2015.10.060","article-title":"Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE Regsitry","volume":"67","author":"Jim\u00e9nez","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"1601732","DOI":"10.1183\/13993003.01732-2016","article-title":"Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model","volume":"49","author":"Becattini","year":"2017","journal-title":"Eur Respir J"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1378\/chest.14-2551","article-title":"Validation of a model for identification of patients at intermediate to high risk for complications associated with acute symptomatic pulmonary embolism","volume":"148","author":"Fernandez","year":"2015","journal-title":"Chest"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.CIR.0000137826.09715.9C","article-title":"Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials","volume":"110","author":"Wan","year":"2004","journal-title":"Circulation"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ajem.2016.06.094","article-title":"Pulseless electrical activity in pulmonary embolism treated with thrombolysis (from the \u2018PEAPETT\u2019 study)","volume":"34","author":"Sharifi","year":"2016","journal-title":"Am J Emergency Med"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jth.12521","article-title":"Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial","volume":"12","author":"Kline","year":"2014","journal-title":"J Thromb Haemost"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2014.5990","article-title":"Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis","volume":"311","author":"Chatterjee","year":"2014","journal-title":"JAMA"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism","volume":"69","author":"Konstantinides","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/rccm.201311-2040OC","article-title":"Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism","volume":"189","author":"Jim\u00e9nez","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate pulmonary embolism treated with thrombolysis (from the \u2018MOPETT\u2019 Trial)","volume":"111","author":"Sharifi","year":"2013","journal-title":"Am J Cardiol"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.thromres.2013.12.026","article-title":"Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis","volume":"133","author":"Zhang","year":"2014","journal-title":"Thromb Res"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/thoraxjnl-2017-210040","article-title":"Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis","volume":"73","author":"Jim\u00e9nez","year":"2018","journal-title":"Thorax"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4329\/wjr.v9.i7.295","article-title":"Interventional radiology treatment for pulmonary embolism","volume":"9","author":"De Gregorio","year":"2017","journal-title":"World J Radiol"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II Study","volume":"8","author":"Piazza","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1378\/chest.15-0119","article-title":"Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): initial results from a prospective multicenter registry","volume":"148","author":"Kuo","year":"2015","journal-title":"Chest"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jcin.2018.04.008","article-title":"A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE Trial","volume":"11","author":"Tapson","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-017-1655-8","article-title":"Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation","volume":"21","author":"Corsi","year":"2017","journal-title":"Crit Care"},{"key":"R24-20230913","article-title":"Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a case series and review of the literature","author":"Al-Bawardy","year":"2018","journal-title":"Perfusion"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.hrtlng.2016.11.005","article-title":"Extracorporeal membrane oxygenation in massive pulmonary embolism","volume":"46","author":"Dolmatova","year":"2017","journal-title":"Heart Lung"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4187\/respcare.01373","article-title":"Inhaled nitric oxide as salvage therapy in massive pulmonary embolism: a case series","volume":"57","author":"Summerfield","year":"2012","journal-title":"Respir Care"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ahj.2017.01.011","article-title":"Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: the iNOPE trial","volume":"186","author":"Kline","year":"2017","journal-title":"Am Heart J"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.chest.2016.03.011","article-title":"A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism","volume":"150","author":"Kabrhel","year":"2016","journal-title":"Chest"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1358863X17730430","article-title":"A pulmonary embolism response team's initial 20 month experience treating 87 patients with sub-massive and massive pulmonary embolism","volume":"23","author":"Sista","year":"2017","journal-title":"Vasc Med"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/21548331.2017.1309954","article-title":"Nuts and bolts of running a pulmonary embolism response team: results from an organizational survey of the National PERT Consortium members","volume":"45","author":"Barnes","year":"2017","journal-title":"Hospital Pract"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075198-201812000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:18:37Z","timestamp":1694632717000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075198-201812000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000558","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}